Literature DB >> 29948879

Zoledronate increases enrichment, activation and expansion of natural killer cells from umbilical cord blood.

Zhijie Ma1, Yunhong Wang2, Huiyan Kang3, Xiaoyun Wu4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29948879     DOI： 10.1007/s13577-018-0213-2

Source DB:  PubMed          Journal:  Hum Cell        ISSN： 0914-7470            Impact factor:   4.174


× No keyword cloud information.
  10 in total

1.  Cord blood: a promising source of allogeneic natural killer cells for immunotherapy.

Authors:  Hila Shaim; Eric Yvon
Journal:  Cytotherapy       Date:  2015-01       Impact factor: 5.414

Review 2.  Umbilical cord blood-derived cellular products for cancer immunotherapy.

Authors:  Jeannette Cany; Harry Dolstra; Nina Shah
Journal:  Cytotherapy       Date:  2015-03-18       Impact factor: 5.414

Review 3.  Expanded and armed natural killer cells for cancer treatment.

Authors:  Noriko Shimasaki; Elaine Coustan-Smith; Takahiro Kamiya; Dario Campana
Journal:  Cytotherapy       Date:  2016-08-03       Impact factor: 5.414

4.  Differential activation of cord blood and peripheral blood natural killer cells by cytokines.

Authors:  Rehab Alnabhan; Alejandro Madrigal; Aurore Saudemont
Journal:  Cytotherapy       Date:  2014-09-22       Impact factor: 5.414

5.  The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation.

Authors:  Martha Luevano; Mehri Daryouzeh; Rehab Alnabhan; Sergio Querol; Salim Khakoo; Alejandro Madrigal; Aurore Saudemont
Journal:  Hum Immunol       Date:  2011-12-28       Impact factor: 2.850

6.  Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.

Authors:  Dongxia Xing; Alan G Ramsay; John G Gribben; William K Decker; Jared K Burks; Mark Munsell; Sufang Li; Simon N Robinson; Hong Yang; David Steiner; Nina Shah; John D McMannis; Richard E Champlin; Chitra Hosing; Patrick A Zweidler-McKay; Elizabeth J Shpall; Catherine M Bollard
Journal:  J Immunother       Date:  2010-09       Impact factor: 4.456

7.  Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.

Authors:  M Kondo; K Sakuta; A Noguchi; N Ariyoshi; K Sato; S Sato; K Sato; A Hosoi; J Nakajima; Y Yoshida; K Shiraishi; K Nakagawa; K Kakimi
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

Review 8.  γδ T Cell Immunotherapy-A Review.

Authors:  Hirohito Kobayashi; Yoshimasa Tanaka
Journal:  Pharmaceuticals (Basel)       Date:  2015-02-12

9.  Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility.

Authors:  Sofia Berglund; Ahmed Gaballa; Piamsiri Sawaisorn; Berit Sundberg; Michael Uhlin
Journal:  Stem Cells Int       Date:  2018-03-07       Impact factor: 5.443

Review 10.  Cord Blood as a Source of Natural Killer Cells.

Authors:  Rohtesh S Mehta; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Front Med (Lausanne)       Date:  2016-01-05
  10 in total
  1 in total

1.  A simple method for in vitro preparation of natural killer cells from cord blood.

Authors:  Yong Xu Mu; Yu Xia Zhao; Bing Yao Li; Hong Jing Bao; Hui Jiang; Xiao Lei Qi; Li Yun Bai; Yun Hong Wang; Zhi Jie Ma; Xiao Yun Wu
Journal:  BMC Biotechnol       Date:  2019-11-21       Impact factor: 2.563
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.